Author:
Jia Yuming,Lei Kaijian,Yuan Zhiping,Wang Jing
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Xu B. New theory of oncologic pharmacology. Beijing: People’s Medical Publishing House, 2005. 5.
2. Airoldi M, Cattel L, Pedani F. Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/relapsed metastatic breast cancer. Acta Oncol, 2003, 42: 186–194.
3. Martín M, Lluch A, Casado A, et al. Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure. Ann Oncol, 2000, 11: 85–89.
4. Tao P, Li ZL, Li H. Clinical study of navelbine plus paclitaxel for patients with advanced breast cancer. Chin Oncol (Chinese), 2006, 16: 61–62.
5. Han WL, Chen CP. Vinorelbine plus paclitaxel for the treatment of 22 cases of metastatic post-operation breast cancer patients. J Chin Physic (Chinese), 2006, 8: 1281.